SNDX - CONSENSUS CO - Syndax Pharmaceuticals

Syndax Pharmaceuticals (SNDX) operates within a closed therapeutic environment for leukemia treatment, where strict FDA regulations determine drug access. This price chart on GURU.Markets, with a value of 37.48, helps track the dynamics of this sector. The business relies on partnerships with scientific centers to combat rare pathologies while remaining dependent on the stability of global raw material supplies.

To assess the fundamental value of Syndax Pharmaceuticals (SNDX), investors must compare the market price with expert expectations. This metric aggregates average target values from DCF models of leading investment houses, reflecting a consolidated view of fair value. By analyzing the analysts' target price indicator, one can determine the asset's growth potential. For Syndax Pharmaceuticals, the forecast is based on the integration of unique oncology drugs into global treatment protocols. The indispensability of this therapy ensures the long-term sustainability of its capitalization.